Previous 10 | Next 10 |
Soleno Therapeutics (NASDAQ: SLNO ) -10% . More news on: Soleno Therapeutics, Inc., Tencent Music Entertainment Group, Cellectar Biosciences, Inc., Stocks on the move, Read more ...
Enanta Pharmaceuticals (NASDAQ: ENTA ) is 3.6% lower after hours on a reported 1.6M-share secondary offering. More news on: Enanta Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...
The following slide deck was published by Enanta Pharmaceuticals, Inc. in conjunction with this Read more ...
Respiratory Syncytial Virus (RSV) Human Challenge Study with EDP-938 ARGON-1 Study in Non-alcoholic Steatohepatitis (NASH) with EDP-305 Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule d...
Nano cap Conatus Pharmaceuticals ( CNAT +22.2% ) is up on more than a 4x surge in volume. Shares have rallied 43% this week. More news on: Conatus Pharmaceuticals Inc., Madrigal Pharmaceuticals, Inc., Viking Therapeutics, Inc., Healthcare stocks news, Stocks on the move, ...
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, will participate in two fir...
At the end of the day, a stock is simply a share in the ownership of a business. Stock prices can fluctuate due to a multiplicity of factors in the short term, but over the long term, the stock price and the value of the business tend to move in the same direction. The more profitable the b...
Market Assessment 2019 is seen as the year of NASH in the biotech industry. The recent top-line data readout for Phase 3 investigative drug candidates, selonsertib by Gilead ( GILD ) and obeticholic acid by Intercept ( ICPT ), further demonstrated the complexity of NASH and the clinical ch...
Viking Therapeutics (NASDAQ: VKTX ) +8.4% and Madrigal Pharmaceuticals (NASDAQ: MDGL ) +3.3% after-hours as Gilead’s (NASDAQ: GILD ) study designed to evaluate a chronic liver disease drug failed to meet its primary endpoint ; GILD -3.6% . More news on: Viking Therapeutic...
Enanta Pharmaceuticals, Inc. (ENTA) Q1 2019 Earnings Conference Call February 6, 2019 4:30 PM ET Company Participants Carol Miceli - Investor Relations Jay Luly - President, Chief Executive Officer and Director Paul Mellett - Senior Vice President, Finance and Administration and ...
News, Short Squeeze, Breakout and More Instantly...
Enanta Pharmaceuticals Inc. Company Name:
ENTA Stock Symbol:
NASDAQ Market:
Enanta Pharmaceuticals Inc. Website:
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, today announced that Jay R. Luly, Ph.D., President and Chief Executive Officer, and Tara L. Kieffer, Ph.D., Chief Product Strate...
2024-05-10 16:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
A look at the top 10 most actives in the United States Nuwellis Inc. (NUWE) rose 60.3% to $0.2741 on volume of 66,284,094 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 21.1% to $0.05 on volume of 64,247,106 shares Clearmind Medicine Inc. (CMND) rose 37.6% to $1.61 on volume ...